You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Melbourne breast cancer trial to test Optiscan imaging device
- 2. Targeting the nuclear orphan receptor NR4A1: a key target in lung cancer progression and therapeutic resistance
- 3. Global research trends in tryptophan metabolism and cancer: a bibliometric and visualization analysis (2005–2024)
- 4. Hsa_circ_0001859 promotes NSCLC progression through the miRNA-101-3p/MMP1 axis
- 5. Case Report: Surgical androgen deprivation therapy for prostate cancer in a patient with concurrent scrotal paget's disease
- 6. Peptone Hosts In-Person Advisory Meeting With Leading Experts in Oncology, Drug Development and Medicinal Chemistry to Advance Small Molecule IDP-Targeted Treatment Solutions
- 7. Prostate cancer classification using 3D deep learning and ultrasound video clips: a multicenter study
- 8. Study reveals mechanisms behind common mutation and prostate cancer
- 9. Assessment of prostate cancer aggressiveness through the combined analysis of prostate MRI and 2.5D deep learning models
- 10. Angiosarcoma: a systematic review of biomarkers in diagnosis, prognosis, and therapeutic strategies
Last updated at 13:18 GMT
Hot News Makers
Health/Pharma Companies
-
19053.91
-
15301.41
-
13982.57
-
12647.89
-
11421.88
-
10393.88
-
10249.54
-
10181.36
-
8735.49
-
8435.99
Drugs, Treatments, Trials
-
14712.26
-
10152.71
-
8150.57
-
8001.78
-
4262.87
-
2534.79
-
1905.65
-
1896.70
-
1759.04
-
1290.92
Last updated at 13:10 GMT
